A detailed history of Simplify Asset Management Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Simplify Asset Management Inc. holds 36,624 shares of NBIX stock, worth $5.22 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
36,624
Previous 46,497 21.23%
Holding current value
$5.22 Million
Previous $5.84 Million 12.03%
% of portfolio
0.29%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$123.98 - $146.67 $1.22 Million - $1.45 Million
-9,873 Reduced 21.23%
36,624 $5.14 Million
Q2 2025

Aug 07, 2025

BUY
$87.54 - $128.18 $2.3 Million - $3.36 Million
26,223 Added 129.34%
46,497 $5.84 Million
Q1 2025

May 13, 2025

BUY
$107.22 - $153.29 $2.17 Million - $3.11 Million
20,274 New
20,274 $2.24 Million
Q2 2024

Aug 12, 2024

BUY
$130.86 - $143.19 $2.99 Million - $3.27 Million
22,834 New
22,834 $3.14 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.6B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.